BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15343272)

  • 1. A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase.
    Hayden PJ; Keogh F; Ni Conghaile M; Carroll M; Crowley M; Fitzsimon N; Gardiner N; Vandenberghe E; O'Riordan J; McCann SR
    Bone Marrow Transplant; 2004 Sep; 34(6):545-56. PubMed ID: 15343272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?
    Hjermstad M; Holte H; Evensen S; Fayers P; Kaasa S
    Bone Marrow Transplant; 1999 Oct; 24(8):911-8. PubMed ID: 10516705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation.
    Harder H; Cornelissen JJ; Van Gool AR; Duivenvoorden HJ; Eijkenboom WM; van den Bent MJ
    Cancer; 2002 Jul; 95(1):183-92. PubMed ID: 12115332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation.
    Worel N; Biener D; Kalhs P; Mitterbauer M; Keil F; Schulenburg A; Höcker P; Dieckmann K; Fischer G; Rosenmayr A; Linkesch W; Hinterberger W; Lechner K; Greinix HT
    Bone Marrow Transplant; 2002 Nov; 30(9):619-26. PubMed ID: 12407437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation.
    Hjermstad MJ; Evensen SA; Kvaløy SO; Loge JH; Fayers PM; Kaasa S
    Psychooncology; 2003 Dec; 12(8):803-13. PubMed ID: 14681953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social support and quality of life of patients prior to stem cell or bone marrow transplantation.
    Frick E; Ramm G; Bumeder I; Schulz-Kindermann F; Tyroller M; Fischer N; Hasenbring M
    Br J Health Psychol; 2006 Sep; 11(Pt 3):451-62. PubMed ID: 16870055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases].
    He Y; Feng SZ; Wang M; Wei JL; Qin TJ; Zhou Z; Zhai WJ; Qiu LG; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):389-92. PubMed ID: 16251016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.
    Pallua S; Giesinger J; Oberguggenberger A; Kemmler G; Nachbaur D; Clausen J; Kopp M; Sperner-Unterweger B; Holzner B
    Bone Marrow Transplant; 2010 Oct; 45(10):1534-9. PubMed ID: 20228854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late mortality and relapse following BuCy2 and HLA-identical sibling marrow transplantation for chronic myelogenous leukemia.
    Copelan EA; Crilley PA; Szer J; Dodds AJ; Stevenson D; Phillips G; Elder P; Nivison-Smith I; Avalos BR; Penza S; Topolsky D; Sobecks R; Kalaycio M; Bolwell BJ
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):851-5. PubMed ID: 19539217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
    Cengiz M; Ozyar E; Esassolak M; Altun M; Akmansu M; Sen M; Uzel O; Yavuz A; Dalmaz G; Uzal C; Hiçsönmez A; Sarihan S; Kaplan B; Atasoy BM; Ulutin C; Abacioğlu U; Demiral AN; Hayran M
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1347-53. PubMed ID: 16169671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation.
    Kiss TL; Abdolell M; Jamal N; Minden MD; Lipton JH; Messner HA
    J Clin Oncol; 2002 May; 20(9):2334-43. PubMed ID: 11981005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life, reproduction and sexuality after stem cell transplantation with partially T-cell-depleted grafts and after conditioning with a regimen including total body irradiation.
    Claessens JJ; Beerendonk CC; Schattenberg AV
    Bone Marrow Transplant; 2006 May; 37(9):831-6. PubMed ID: 16547485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and difficulties of patients encountered after autologous stem cell transplantation.
    Kav S; Aslan O; Tekin F; Yesil H; Meral C; Ozturk U; Bulut Z; Enaboifo A; Yazar B
    J BUON; 2009; 14(4):673-80. PubMed ID: 20148461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life following allogeneic stem cell transplantation, comparing parents' and children's perspective.
    Forinder U; Löf C; Winiarski J
    Pediatr Transplant; 2006 Jun; 10(4):491-6. PubMed ID: 16712609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in adult survivors after paediatric allo-SCT.
    Löf CM; Winiarski J; Giesecke A; Ljungman P; Forinder U
    Bone Marrow Transplant; 2009 Mar; 43(6):461-8. PubMed ID: 18936733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transplant outcome in chronic myeloid leukaemia.
    Raza S; Ullah K; Ahmed P; Khan B; Kamal MK
    J Coll Physicians Surg Pak; 2008 Oct; 18(10):615-9. PubMed ID: 18940118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
    Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G;
    Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.